Clinical Trial Update: Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial compares two cycles versus three cycles of concurrent chemoradiotherapy for low-risk locoregionally advanced nasopharyngeal carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN